Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

ClinicalTrials.gov ID: NCT06012435

Public ClinicalTrials.gov record NCT06012435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 1:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY TO EVALUATE SIGVOTATUG VEDOTIN COMPARED WITH DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (BE6A LUNG-01)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer that has spread through their body or can't be removed with surgery. Participants in this study must have been treated with no more than a platinum-based chemotherapy and an anti-PD-(L)1 drug. Participants with tumors that have certain treatable genomic alterations must have had at least 1 drug for that genomic alteration, in addition to platinum-based chemotherapy. This clinical trial uses an experimental drug called sigvotatug vedotin, which is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. This clinical trial also uses a drug called docetaxel. Docetaxel is an anticancer drug that has been approved to treat non-small cell lung cancer. It is usually given to patients who previously received another anticancer treatment. In this study, one group of participants will get sigvotatug vedotin on Days 1 and 15 during each 28-day-cycle. A second group of participants will get docetaxel on Day 1 during each 21-day cycle. This study is being done to see if sigvotatug vedotin works better than docetaxel to treat participants with NSCLC. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease.

Study identification

NCT ID
NCT06012435
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
762 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 21, 2024 (Actual)
Primary completion
May 18, 2026 (Actual)
Completion
May 17, 2028 (Estimated)
Last update posted
Jul 23, 2026

2024 – 2028

United States locations

U.S. sites
130
U.S. states
20
U.S. cities
94
Facility City State ZIP Site status
Alaska Oncology and Hematology, LLC Anchorage Alaska 99508 —
Providence Medical Foundation Fullerton California 92835 —
Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center Fullerton California 92835 —
Providence St. Jude Medical Center Fullerton California 92835 —
Cancer and Blood Specialty Clinic Los Alamitos California 90720 —
Cancer Blood and Specialty Clinic Los Alamitos California 90720 —
Regulatory Management Only: TRIO-US Central Administration Los Angeles California 90024 —
Drug Management Only: UCLA West Medical Pharmacy Attn: Steven L. Wong, Pharma.D. Los Angeles California 90095 —
Drug Management Only: UCLA West Medical Pharmacy, Attn: Steven L Wong, Pharm.D. Los Angeles California 90095 —
UCSF Medical Center - Mission Bay San Francisco California 94158 —
Sansum Clinic Santa Barbara California 93105 —
Sansum Clinic Solvang California 93463 —
Rocky Mountain Cancer Centers LLP Aurora Colorado 80012 —
Rocky Mountain Cancer Centers LLP Boulder Colorado 80303 —
Rocky Mountain Cancer Centers LLP Colorado Springs Colorado 80907 —
Rocky Mountain Cancer Centers LLP Colorado Springs Colorado 80923 —
Rocky Mountain Cancer Centers LLP Denver Colorado 80218 —
Rocky Mountain Cancer Centers LLP Denver Colorado 80220 —
Rocky Mountain Cancer Centers LLP Lakewood Colorado 80228 —
Rocky Mountain Cancer Centers LLP Littleton Colorado 80120 —
Rocky Mountain Cancer Centers LLP Lone Tree Colorado 80124 —
Rocky Mountain Cancer Centers LLP Longmont Colorado 80504 —
Rocky Mountain Cancer Centers LLP Pueblo Colorado 81003 —
Rocky Mountain Cancer Centers LLP Thornton Colorado 80260 —
Cancer Specialists of North Florida Fleming Island Florida 32003 —
Cancer Specialists of North Florida Jacksonville Florida 32204 —
Cancer Specialists of North Florida Jacksonville Florida 32218 —
Cancer Specialists of North Florida Jacksonville Florida 32256 —
Cancer Specialists of North Florida Jacksonville Florida 32258 —
Cancer Care Centers of Brevard, Inc. Melbourne Florida 32935 —
Baptist Hospital of Miami Miami Florida 33176 —
Miami Cancer Institute at Baptist Health, Inc. Miami Florida 33176 —
Cancer Specialists of North Florida Neptune Beach Florida 32266 —
Cancer Care Centers of Brevard, Inc. Palm Bay Florida 32901 —
Cancer Care Centers of Brevard, Inc. Rockledge Florida 32955 —
Cancer Specialists of North Florida Saint Augustine Florida 32086 —
Illinois Cancer Specialists Arlington Heights Illinois 60005 —
Illinois Cancer Specialists Niles Illinois 60714 —
Maryland Oncology Hematology P.A. Annapolis Maryland 21401 —
Maryland Oncology Hematology P.A. Bethesda Maryland 20817 —
Maryland Oncology Hematology P.A. Brandywine Maryland 20613 —
Maryland Oncology Hematology P.A. Columbia Maryland 21044 —
Maryland Oncology Hematology P.A. Germantown Maryland 20876 —
Maryland Oncology Hematology P.A. Largo Maryland 20774 —
Maryland Oncology Hematology P.A. Rockville Maryland 20850 —
Maryland Oncology Hematology P.A. Silver Spring Maryland 20904 —
Boston Medical Center Boston Massachusetts 02118 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Southcoast Centers for Cancer Care Fairhaven Massachusetts 02719 —
Southcoast Centers for Cancer Care Fall River Massachusetts 02720 —
Allina Health Cancer Institute - Mercy Hospital Coon Rapids Minnesota 55433 —
Allina Health Cancer Institute - Abbott Northwestern Hospital Minneapolis Minnesota 55407 —
Allina Health Cancer Institute - United Hospital Saint Paul Minnesota 55102 —
Hattiesburg Clinic Hematology/Oncology. Hattiesburg Mississippi 39401 —
St Luke's Cancer Institute Kansas City Missouri 64111 —
Nebraska Medicine Bellevue Nebraska 68123 —
Nebraska Medicine Omaha Nebraska 68105 —
Nebraska Medicine Omaha Nebraska 68118 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Summit Medical Group Florham Park New Jersey 07932 —
NYU Langone Hospital - Long Island Mineola New York 11501 —
Perlmutter Cancer Center at NYU Langone Hospital - Long Island Mineola New York 11501 —
Laura & Isaac Perlmutter Cancer Center - NYU ACC New York New York 10016 —
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016 —
NYU Langone Medical Center (Tisch Hospital) New York New York 10016 —
University Hospitals Seidman Cancer Center at UH Avon Health Center Avon Ohio 44011 —
Oncology Hematology Care Clinical Trials, LLC Cincinnati Ohio 45211 —
Oncology Hematology Care Clinical Trials, LLC Cincinnati Ohio 45242 —
Oncology Hematology Care Clinical Trials, LLC Cincinnati Ohio 45245 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Cleveland Clinic Cancer Center/Fairview Hospital Moll Cancer Pavilion Cleveland Ohio 44111 —
Oncology Hematology Care Clinical Trials, LLC Fairfield Ohio 45014 —
Taylor Cancer Research Center Maumee Ohio 43537 —
Cleveland Clinic Cancer Center/Hillcrest Hospital Cancer Center Pharmacy Mayfield Heights Ohio 44124 —
University Hospitals Seidman Cancer Center at UH Mentor Health Center Mentor Ohio 44060 —
UH Minoff Health Center at Chagrin Highlands Orange Ohio 44122 —
Oregon Health and Science University - CHO Beaverton Beaverton Oregon 97006 —
Oncology Associates of Oregon, P.C. Eugene Oregon 97401 —
Oregon Health and Science University - CHO Gresham Gresham Oregon 97030 —
Oregon Health and Science University - CHO Northwest Portland Oregon 97210 —
Northwest Cancer Specialists, P.C. Portland Oregon 97213 —
Oregon Health and Science University - CHO East Portland Portland Oregon 97216 —
Northwest Cancer Specialists, P.C. Portland Oregon 97227 —
Oregon Health and Science University (CHH1) Portland Oregon 97239 —
Oregon Health and Science University (CHH2) Portland Oregon 97239 —
Oregon Health and Science University Portland Oregon 97239 —
Northwest Cancer Specialists, P.C. Tigard Oregon 97223 —
Oregon Health and Science University - CHO Tualatin Tualatin Oregon 97062 —
Alliance Cancer Specialists, PC Bensalem Pennsylvania 19020 —
Alliance Cancer Specialists, PC Doylestown Pennsylvania 18901 —
Alliance Cancer Specialists, PC Horsham Pennsylvania 19044 —
Alliance Cancer Specialists, PC Langhorne Pennsylvania 19047 —
Alliance Cancer Specialists, PC Media Pennsylvania 19063 —
Alliance Cancer Specialists, PC Sellersville Pennsylvania 18960 —
Alliance Cancer Specialists, PC Wynnewood Pennsylvania 19096 —
Texas Oncology - West Texas Abilene Texas 79606 —
Texas Oncology - West Texas Amarillo Texas 79124 —
Texas Oncology - Central South Austin Texas 78705 —
Texas Oncology - Central South Austin Texas 78731 —
Texas Oncology - Central South Austin Texas 78745 —
University of Texas Southwestern Medical Center - Simmons Cancer Center Dallas Texas 75235 —
UT Southwestern Medical Center - Redbird Dallas Texas 75237 —
Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital Dallas Texas 75390 —
University of Texas Southwestern Medical Center - William P. Clements, Jr., University Hospital Dallas Texas 75390 —
University Of Texas Southwestern Medical Center Dallas Texas 75390 —
Texas Oncology - West Texas El Paso Texas 79902 —
Texas Oncology - West Texas El Paso Texas 79915 —
Texas Oncology - West Texas El Paso Texas 79938 —
UT Southwestern - Simmons Cancer Center - Fort Worth Fort Worth Texas 76104 —
US Oncology Investigational Product Center (IPC) Irving Texas 75063 —
US Oncology Investigational Products Center (IPC) Irving Texas 75063 —
Texas Oncology - West Texas Midland Texas 79701 —
Texas Oncology - West Texas Odessa Texas 79761 —
UT Southwestern - Simmons Cancer Center - Richardson/Plano Richardson Texas 75080 —
Texas Oncology - Central South Waco Texas 76712 —
Texas Oncology - West Texas Wichita Falls Texas 76310 —
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Blacksburg Virginia 24060 —
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Low Moor Virginia 24457 —
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Roanoke Virginia 24014 —
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Salem Virginia 24153 —
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Wytheville Virginia 24382 —
Northwest Medical Specialties, PLLC Bonney Lake Washington 98391 —
Northwest Medical Specialties, PLLC Federal Way Washington 98003 —
Northwest Medical Specialties, PLLC Gig Harbor Washington 98332 —
American Oncology Network Vista Oncology Division-West office Olympia Washington 98502 —
American Oncology Network Vista Oncology Division Olympia Washington 98506 —
Northwest Medical Specialties, PLLC Puyallup Washington 98373 —
Northwest Medical Specialties, PLLC Tacoma Washington 98405 —
Northwest Cancer Specialists, P.C. Vancouver Washington 98684 —
Froedtert Hospital/Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 201 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06012435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06012435 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →